These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36966130)

  • 1. Bacterial outer membrane vesicle based versatile nanosystem boosts the efferocytosis blockade triggered tumor-specific immunity.
    Zhuang WR; Wang Y; Nie W; Lei Y; Liang C; He J; Zuo L; Huang LL; Xie HY
    Nat Commun; 2023 Mar; 14(1):1675. PubMed ID: 36966130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytochemical Engineered Bacterial Outer Membrane Vesicles for Photodynamic Effects Promoted Immunotherapy.
    Zhuang WR; Wang Y; Lei Y; Zuo L; Jiang A; Wu G; Nie W; Huang LL; Xie HY
    Nano Lett; 2022 Jun; 22(11):4491-4500. PubMed ID: 35605283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen Capture and Immune Modulation by Bacterial Outer Membrane Vesicles as In Situ Vaccine for Cancer Immunotherapy Post-Photothermal Therapy.
    Li Y; Zhang K; Wu Y; Yue Y; Cheng K; Feng Q; Ma X; Liang J; Ma N; Liu G; Nie G; Ren L; Zhao X
    Small; 2022 Apr; 18(14):e2107461. PubMed ID: 35152555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
    Myers Chen KV; de Groot AE; Mendez SA; Mallin MM; Amend SR; Pienta KJ
    Med Oncol; 2023 Aug; 40(10):284. PubMed ID: 37644281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP.
    Zhou Y; Fei M; Zhang G; Liang WC; Lin W; Wu Y; Piskol R; Ridgway J; McNamara E; Huang H; Zhang J; Oh J; Patel JM; Jakubiak D; Lau J; Blackwood B; Bravo DD; Shi Y; Wang J; Hu HM; Lee WP; Jesudason R; Sangaraju D; Modrusan Z; Anderson KR; Warming S; Roose-Girma M; Yan M
    Immunity; 2020 Feb; 52(2):357-373.e9. PubMed ID: 32049051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Bacterial Outer Membrane Vesicles as Controllable Two-Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor Immunotherapy.
    Feng Q; Ma X; Cheng K; Liu G; Li Y; Yue Y; Liang J; Zhang L; Zhang T; Wang X; Gao X; Nie G; Zhao X
    Adv Mater; 2022 Oct; 34(40):e2206200. PubMed ID: 35985666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1.
    Werfel TA; Elion DL; Rahman B; Hicks DJ; Sanchez V; Gonzales-Ericsson PI; Nixon MJ; James JL; Balko JM; Scherle PA; Koblish HK; Cook RS
    Cancer Res; 2019 Jan; 79(1):171-182. PubMed ID: 30413412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer.
    Zhou X; Li D; Xia S; Ma X; Li R; Mu Y; Liu Z; Zhang L; Zhou Q; Zhuo W; Ding K; Lin A; Liu W; Liu X; Zhou T
    J Control Release; 2024 Feb; 366():128-141. PubMed ID: 38104775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified bacterial outer membrane vesicles induce autoantibodies for tumor therapy.
    Huang W; Shu C; Hua L; Zhao Y; Xie H; Qi J; Gao F; Gao R; Chen Y; Zhang Q; Li W; Yuan M; Ye C; Ma Y
    Acta Biomater; 2020 May; 108():300-312. PubMed ID: 32251780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioengineered Bacterial Membrane Vesicles with Multifunctional Nanoparticles as a Versatile Platform for Cancer Immunotherapy.
    Liu XZ; Wen ZJ; Li YM; Sun WR; Hu XQ; Zhu JZ; Li XY; Wang PY; Pedraz JL; Lee JH; Kim HW; Ramalingam M; Xie S; Wang R
    ACS Appl Mater Interfaces; 2023 Jan; 15(3):3744-3759. PubMed ID: 36630299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Real-Time Image-Based Efferocytosis Assay for the Discovery of Functionally Inhibitory Anti-MerTK Antibodies.
    Bravo DD; Shi Y; Sheu A; Liang WC; Lin W; Wu Y; Yan M; Wang J
    J Immunol; 2023 Apr; 210(8):1166-1176. PubMed ID: 36881873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MerTK as a therapeutic target in glioblastoma.
    Wu J; Frady LN; Bash RE; Cohen SM; Schorzman AN; Su YT; Irvin DM; Zamboni WC; Wang X; Frye SV; Ewend MG; Sulman EP; Gilbert MR; Earp HS; Miller CR
    Neuro Oncol; 2018 Jan; 20(1):92-102. PubMed ID: 28605477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redirecting Antigens by Engineered Photosynthetic Bacteria and Derived Outer Membrane Vesicles for Enhanced Cancer Immunotherapy.
    Han D; Wang F; Ma Y; Zhao Y; Zhang W; Zhang Z; Liu H; Yang X; Zhang C; Zhang J; Li Z
    ACS Nano; 2023 Oct; 17(19):18716-18731. PubMed ID: 37782086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
    Nishi C; Yanagihashi Y; Segawa K; Nagata S
    J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface Mineralization of Engineered Bacterial Outer Membrane Vesicles to Enhance Tumor Photothermal/Immunotherapy.
    Chen X; Li P; Luo B; Song C; Wu M; Yao Y; Wang D; Li X; Hu B; He S; Zhao Y; Wang C; Yang X; Hu J
    ACS Nano; 2024 Jan; 18(2):1357-1370. PubMed ID: 38164903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression.
    Lin J; Xu A; Jin J; Zhang M; Lou J; Qian C; Zhu J; Wang Y; Yang Z; Li X; Yu W; Liu B; Tao H
    Oncoimmunology; 2022; 11(1):2024941. PubMed ID: 35036076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioengineered Nanospores Selectively Blocking LC3-Associated Phagocytosis in Tumor-Associated Macrophages Potentiate Antitumor Immunity.
    Shang Y; Lu H; Liao L; Li S; Xiong H; Yao J
    ACS Nano; 2023 Jun; 17(11):10872-10887. PubMed ID: 37192052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocatechuic acid boosts continual efferocytosis in macrophages by derepressing KLF4 to transcriptionally activate MerTK.
    Li Q; Liu X; Du Y; Zhang X; Xiang P; Chen G; Ling W; Wang D
    Sci Signal; 2023 May; 16(786):eabn1372. PubMed ID: 37220181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the Immune Response to Tumor Cell Apoptosis and Efferocytosis.
    Werfel TA
    Methods Mol Biol; 2022; 2543():45-55. PubMed ID: 36087258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioengineered bacterial outer membrane vesicles encapsulated Polybia-mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy.
    Ren C; Li Y; Cong Z; Li Z; Xie L; Wu S
    Front Immunol; 2023; 14():1129771. PubMed ID: 36999028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.